Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06849752Recruiting

Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF

Role: collaborator

NCT06792851Not ApplicableCompleted

ECHO-012 Kosmos Bladder Clinical Validation Study

Role: lead

NCT06468787Not ApplicableCompleted

Kosmos Anatomical Object Labeling and View Identification Pivotal Study

Role: lead

NCT06449872Not ApplicableCompleted

OB-GYN Clinical Validation Study

Role: lead

NCT06027164Completed

Kosmos Trio and Ejection Fraction Pivotal Study

Role: lead

NCT06065163Not ApplicableUnknown

Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome

Role: collaborator

All 6 trials loaded